Hirakata, Japan

Tomoyuki Maruyama

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomoyuki Maruyama. Retrieved from https://idiyas.com/inventor/tomoyuki-maruyama-e5l601nj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tomoyuki Maruyama

Introduction: Tomoyuki Maruyama is a notable inventor based in Hirakata, Japan, recognized for his contributions to medical technology. With a focus on addressing significant health issues, Maruyama's innovation stands out in the realm of therapeutic solutions.

Latest Patents: Maruyama holds a patent for a therapeutic agent aimed at treating spinal canal stenosis. This condition can lead to severe pain and mobility issues, and Maruyama's invention potentially offers a much-needed remedy for those suffering from it.

Career Highlights: Throughout his career, Tomoyuki Maruyama has demonstrated a commitment to advancing medical treatments. His singular patented invention reflects his dedication to improving patient outcomes and his innovative approach within the healthcare sector.

Collaborations: Maruyama has collaborated with esteemed colleagues, including Toru Kawamura and Toshiaki Akira. These partnerships have likely enriched his work and contributed to the development of effective solutions in the medical field.

Conclusion: Tomoyuki Maruyama's innovations are an integral part of ongoing efforts to enhance medical treatments for spinal canal stenosis. His contributions, along with collaborative efforts with fellow experts, signify the potential for future advancements in healthcare, illustrating the importance of innovation in improving lives.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…